On May 28, I wrote that Snowflake, the cloud-based data software platform company, had changed my mind. I forecast a higher value for SNOW stock. I projected that it would hit $300 based on my free cash flow (FCF) estimates and FCF yield metrics. Source: rblfmr / Shutterstock.com SNOW stock closed on Sept. 23 at
Stocks to buy
Addressing climate change has been a top priority since day one for the Biden administration. Their longer-term agenda being to halve the U.S. carbon footprint by 2030. This sent a lot of “clean-energy” stocks skyrocketing in the early part of the year. One is Clean Energy Fuels (NASDAQ:CLNE) stock. Source: ZikG / Shutterstock.com After trading
The Evergrande crisis seems like China’s Lehmann moment. The markets have been jittery and it remains to be seen if there is a larger spill-over. Amidst this concern, the markets continue to provide investing and speculative opportunities. If I had to focus on buying large-caps, I would look at low-beta stocks. These stocks would protect
Right now, you can say that Sundial Growers (NASDAQ:SNDL) is low-priced, but not cheap. In other words, shares are overvalued at 70 cents per share. Despite the fact the stock has fallen more than 82% off of its meme stock high set in February. Source: Postmodern Studio / Shutterstock.com The reason? Largely, the company’s heavily-dilutive
Given the powerful demand for semiconductors and the steps that Intel (NASDAQ:INTC) is taking to strengthen its supply chain, the medium-term and long-term outlook of INTC stock appears to be strong. Source: Shutterstock Under the leadership of its new CEO, the tech company appears to be improving the quality of its manufacturing process. Furthermore, the
Advanced Micro Devices (NASDAQ:AMD) is now producing large amounts of free cash flow (FCF). This is apparent from its latest second-quarter results for the quarter ending June 26. As a result, AMD stock is likely to move up to 16% higher to $120 per share. This article will explain how I came up with that
Market sentiment has once again soured on Canadian marijuana producers like Canopy Growth (NASDAQ:CGC). The past few years of poor results are still fresh in the minds of investors. This can be clearly seen in CGC stock, which rallied to a high of more than $50 from late last year to February. Source: Shutterstock Canopy Growth
Commodity prices keep rising amid various supply chain disruptions. That’s causing panic buying of raw materials. As a result, many commodity stocks have reported strong numbers in their recent earnings reports, and banking analysts seem to think that inflationary prices will continue to drive earnings higher. I’d argue that there’s an added dynamic to many
Cybersecurity technology company CrowdStrike (NASDAQ:CRWD) has given investors plenty to cheer about lately. CRWD stock has risen nearly 30% so far in 2021 and 78% over the past year. Source: Shutterstock That kind of growth has led many investors to question whether a slowdown is imminent. The good news is that it doesn’t appear to
The markets are far from efficient right now, with several undervalued stocks that boast historically-stable cash flows, scandal-free operations, and a robust profitability profile, relegated to the background. Most of the column inches and headlines are reserved for hyper-growth stocks and exciting recovery plays. Post-pandemic, the outlook for several exceptional stocks remains pessimistic because of
At the end of last year, I wrote that analysts’ earnings projections for Moderna (NASDAQ:MRNA) were $9.46 per share for 2021. Now those same analysts have average earnings per share (EPS) forecasts of $30.12 for 2021, or over 3 times the prior numbers. I wrote that MRNA stock was worth $180. But as of Friday,
I bet many readers are scanning through screeners and news articles trying to find out what the future holds for DraftKings (NASDAQ:DKNG) stock. Well, I’d like you all to remember that if you have a long enough investment horizon, the short-term noise in DKNG stock — or any stock — won’t matter. If you analyze
The markets are entering the last quarter of another eventful year for equities as an asset class. Without doubt, the year will be remembered for Reddit and Meme stocks. It’s also a year when Robinhood (NASDAQ:HOOD) trading platform gained significant traction as millennials took a plunge into stock trading. In general, meme stocks were among
It’s no secret the investing world is obsessed with all-electric vehicles (EVs). Several EV stocks, Tesla (NASDAQ:TSLA) being chief among them, have given investors triple-digit gains this year. But in recent weeks, the stocks have seen a correction. Against this backdrop, QuantumScape (NYSE:QS) stock, down 12.5% last month, becomes an interesting play. Source: Michael Vi/Shutterstock.com
Cassava Sciences (NASDAQ:SAVA), the Alzheimer’s disease (AD) drug company, certainly has had a rough time. In fact, one author recently called SAVA stock a “volatile, battleground stock.” This is because the company has endured a number of short attacks recently. Most of these came out after their recent September release of 9-month Phase 2 results.
Nio (NYSE:NIO) stock is in a slump. It’s not anywhere near the extent of punishment it suffered in 2019 when NIO stock plummeted 85% in 8 months. However, NIO is down 29% from the end of June when it was trading just over the $53 mark. And it’s down about 30% since the start of the
Cinema stocks weren’t buzzworthy until 2021 when movie theater chain AMC Entertainment (NYSE:AMC) became a target of Reddit traders. Once they took hold of AMC stock, all bets were off and the share price soared. Source: QualityHD / Shutterstock.com Indeed, it wouldn’t be unreasonable to call 2021 the “Year of the Meme Stock.” Yet, will this wild
Prior to 2020, arguably the general political consensus was that former President Donald Trump would easily win reelection. Though he has always had rough edges that made him a polarizing figure, President Trump got things done. In turn, his no-nonsense approach to high-level negotiations represented a narrative boon for infrastructure stocks, what with the America
A pharmaceutical play, Novavax (NASDAQ:NVAX) has been on the move. In fact, NVAX stock has risen nearly three times higher since November of last year. Source: Ascannio/Shutterstock.com This leap is primarily due to the company’s Covid-19 vaccine inching closer to commercial release. However, despite the price appreciation, I believe there is still plenty of upside
The bull market on Wall Street has been going on for at least eight years. Late last week equities hit a small snag, and sellers stepped in early everyday and ruined a perfectly strong open. Even before Wednesday’s pop, they were still 2% away from the all time highs. Therefore, investors should be looking for